Cargando…

A Robust Immuno-Prognostic Model of Non-Muscle-Invasive Bladder Cancer Indicates Dynamic Interaction in Tumor Immune Microenvironment Contributes to Cancer Progression

Non-muscle-invasive bladder cancer (NMIBC) accounts for more than 70% of urothelial cancer. More than half of NMIBC patients experience recurrence, progression, or metastasis, which essentially reduces life quality and survival time. Identifying the high-risk patients prone to progression remains th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiaomeng, Xu, Huilin, Liu, Gang, Chen, Jiani, Xu, Jinrong, Li, Mingming, Liu, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205430/ https://www.ncbi.nlm.nih.gov/pubmed/35719408 http://dx.doi.org/10.3389/fgene.2022.833989

Ejemplares similares

Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts
por: Liang, Shengjie, et al.
Publicado: (2022)

Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis
por: Zhang, Shun, et al.
Publicado: (2022)

Characterization of the microenvironment in different immune-metabolism subtypes of cervical cancer with prognostic significance
por: Lai, Wujiang, et al.
Publicado: (2023)

Identification of Microenvironment-Related Prognostic Genes in Bladder Cancer Based on Gene Expression Profile
por: Luo, Yongxiang, et al.
Publicado: (2019)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer
por: Mo, Xiaocong, et al.
Publicado: (2022)

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022)

Exploring prognostic indicators in the pathological images of ovarian cancer based on a deep survival network
por: Wu, Meixuan, et al.
Publicado: (2023)

Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients
por: Lin, Gaoteng, et al.
Publicado: (2020)

The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses
por: Xu, Chenyang, et al.
Publicado: (2022)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer
por: Wu, Yue, et al.
Publicado: (2021)

Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
por: Huo, Xiao, et al.
Publicado: (2021)

Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer
por: Zhang, Hongxian, et al.
Publicado: (2021)

RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer
por: Mu, Lan-Xin, et al.
Publicado: (2022)

Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer
por: He, Yang, et al.
Publicado: (2021)

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
por: Yi, Ruibin, et al.
Publicado: (2020)

Prognostic Value and Therapeutic Perspectives of CXCR Members in the Glioma Microenvironment
por: He, Jiarong, et al.
Publicado: (2022)

Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer
por: Wu, WenBo, et al.
Publicado: (2021)

An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer
por: Liu, Qing, et al.
Publicado: (2022)

Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer
por: He, Yang, et al.
Publicado: (2022)

A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian Cancer
por: Zhang, Mengjun, et al.
Publicado: (2022)

A prognostic exosome-related LncRNA risk model correlates with the immune microenvironment in liver cancer
por: Su, Duntao, et al.
Publicado: (2022)

Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer
por: Cao, Lichao, et al.
Publicado: (2022)

Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
por: Zhang, Mengjun, et al.
Publicado: (2022)

SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer
por: Xia, Qi-Dong, et al.
Publicado: (2022)

Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment
por: Xu, Fangfang, et al.
Publicado: (2021)

Discovery of Notch Pathway-Related Genes for Predicting Prognosis and Tumor Microenvironment Status in Bladder Cancer
por: Sun, Xianchao, et al.
Publicado: (2022)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020)

SEC23A Is an Independent Prognostic Biomarker in Bladder Cancer Correlated With MAPK Signaling
por: Zeng, Bin, et al.
Publicado: (2021)

Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)

CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer
por: Wang, Jianxin, et al.
Publicado: (2020)

Bioinformatics-Based Identification of Tumor Microenvironment-Related Prognostic Genes in Pancreatic Cancer
por: Chen, Shaojie, et al.
Publicado: (2021)

Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis
por: Lin, Yuda, et al.
Publicado: (2023)

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
por: Liu, Ji, et al.
Publicado: (2022)

Integrative Bioinformatics Approaches to Screen Potential Prognostic Immune-Related Genes and Drugs in the Cervical Cancer Microenvironment
por: Zhao, Zitong, et al.
Publicado: (2020)

A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer
por: Xiao, Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6ckpr49hqip4otpmejfm5qsmls